Video & Transcript Research : 'marijuana'

Page 4 of 51
TX
Transcript Highlights:
  • First of all, states have legalized marijuana.
  • Marijuana is federally.
  • I'm a proponent and purveyor of legal marijuana.
  • Marijuana is a Schedule 1 narcotic.
  • Therefore, marijuana will never be legal.
OK

Oklahoma 2026 Regular Session

Health and Human Services Oversight REVISED: SB1304 - Added Apr 15th, 2026 at 03:00 pm

Health and Human Services Oversight

Transcript Highlights:
  • Of changing, getting rid of the marijuana bonds that aren't working in lieu of a fee that would go into
  • Could I have someone from medical marijuana authority helped me with answer this because we had this
  • I'm Megan Hansen, Chief of Staff at Oklahoma Medical Marijuana Authority.
  • This legislation seeks to put abandoned marijuana grows under public nuisance laws.
  • Marijuana grows under public nuisance laws, which could trigger different actions.
AL

Alabama 2026 1st Special Session

Alabama Senate Judiciary Committee Feb 3rd, 2026

Judiciary

Transcript Highlights:
  • But it didn't have vaping marijuana? >> Dealt with smoking tobacco. >> Gotcha.
  • But it didn't have vaping marijuana marijuana marijuana >> dealt<00:34:17.200> with<00:34
OK
Transcript Highlights:
  • House Bill 3143 by Cornwell of the House and Alvot of the Senate, an act relating to medical marijuana
  • Members, House Bill 3143 is basically extending the moratorium on marijuana licensing currently expires
  • Does this include successful businesses that are in good standing with the medical marijuana authority
  • The state's such as California, Colorado, other states who have been leading the edge in the marijuana
  • House and Alvord of the Senate, an act relating to medical marijuana.
OK
Transcript Highlights:
  • House Joint Resolution 1101 by Kendri of the House, a resolution relating to the Oklahoma Medical Marijuana
  • Its hearings of the board may fill in up to 6 hours of C or sea on medical marijuana over the two years
  • Speaker, is we're allowing the medical marijuana association, the ability to use third-party educators
  • It allows the board of podiatry to decide which medical marijuana courses that are offered by the medical
  • marijuana are appropriate.
OK
Transcript Highlights:
  • was in response to the increased costs that were put onto county sheriff's offices from medical marijuana
  • should receive some of that revenue to help alleviate the expenses they've received in response to marijuana
OK
Transcript Highlights:
  • House Bill 4454 by Newton of the House and Yuck of the Senate, an act relating to medical marijuana.
  • A bill to protect our young ones that edible marijuana would not be made in shapes that are attractive
  • House Bill 4454 by Newton of the House and Yuck of the Senate, an act relating to medical marijuana.
OK
Transcript Highlights:
  • So, what is to stop an employer who tests their employee who did use medical marijuana two weeks prior
  • If the employee that gets ran over by the skid steer used marijuana a month prior, and they do a hair
  • in the system that could have dated back a month prior, and they have a legitimate medical marijuana
  • The state of Oklahoma enacted medical marijuana and There is a process for that.
  • Then yes, just for the fact of having a medical marijuana card, no.
MO

Missouri 2026 Regular Session

Crime and Public Safety Jan 13th, 2026

Crime and Public Safety

Transcript Highlights:
  • Are they considered marijuana or are they not considered marijuana? Okay. Thank you.
  • Labeling it marijuana is not marijuana, though. There are two different things.
  • or marijuana altogether.
  • Marijuana. Okay.
  • Ziploc bags of marijuana.
Keywords: 959, house, all
FL

Florida 2025 Regular Session

February 4, 2025 - 12:30 PM

Transcript Highlights:
  • for Medical Marijuana Clinical Outcomes Research on various aspects of Florida's medical marijuana program
  • So our statute talks about marijuana in three forms.
  • I think how I may choose to answer that might be medical marijuana, and even marijuana around the country
  • Medical marijuana, only about 2,000.
  • As you can tell from the medical marijuana treatment centers, most of the medical marijuana users live
Summary: The Health Professions and Program Subcommittee met to receive oversight briefings on Florida’s medical marijuana program from the Department of Health’s Office of Medical Marijuana Use (OMMU) and from the University of Florida’s Consortium for Medical Marijuana Clinical Outcomes Research. OMMU Director Christopher Kimball outlined the program’s structure, including more than 900,000 active patients, nearly 7,000 caregivers, 27 MMTC licensees, 706 dispensing locations, and nine certified testing labs. He described the state’s pre-approval process for products and advertising, plain packaging requirements, seed-to-sale tracking, registry operations, and compliance efforts such as background checks, inspections, complaint investigations, and lab desk audits. He also said the Bureau of Public Health Laboratories in Jacksonville had been accredited to begin supporting testing. Members asked about telehealth, patient growth, product safety, advertising to children, inspections, and the status of MMTC licensure; Kimball said recertifications by telehealth now make up more than half of recertifications, that patient growth has slowed, and that ongoing litigation is delaying issuance of 22 new MMTC licenses. Kimball also discussed implementation of recent legislation and licensure changes, including licenses issued under HB 387 and SB 1582 to applicants from the original Pigford-related pool, with additional cure opportunities still ongoing. He said the department is monitoring diversion, inversion, and unapproved products, and that it coordinates with law enforcement when needed but does not itself have sworn authority. In response to questions, he said the department does not regulate physicians directly, but may refer concerns to the Division of Medical Quality Assurance, and that caregiver and physician participation requirements are set by statute. Members raised concerns about edibles, child access, and continued use of child-attractive branding; Kimball said the department tries to catch issues through pre-approval and enforcement, and that complaints involving children are treated as serious and investigated using available records and camera footage. Dr. Almond Winterstein then presented the consortium’s research overview. He explained that the consortium was created by statute in 2019, includes 10 universities, and is funded by annual state appropriations. He said its work includes grants, a research repository, a clinical core, outreach, and evidence synthesis, including a recent FDA-supported review of cannabis evidence. He emphasized that the current evidence base is limited and often low quality, with the strongest signals for symptom relief in PTSD-related symptoms, nausea, and some pain outcomes, but with many studies inconclusive or mixed. He also described the consortium’s use of registry data linked to Medicaid, Medicare, death, fetal death, and birth records to study safety and outcomes, including children, pregnancy, driving safety, opioid-sparing effects, and adverse events. Winterstein said adverse event reporting is sparse and likely underreported, with most reports mild but some serious events noted, and he expressed concern about use among young adults because of uncertain benefit-risk and possible effects on the developing brain. The committee discussed the need for better surveillance, more robust adverse event reporting, and the possibility of using linked data to identify harms more quickly. At the end of the meeting, the committee rose without objection.
MA
Transcript Highlights:
  • 2012 legalized medical marijuana.
  • Next slide. 30% of marijuana users have some form of marijuana use disorder.
  • Marijuana, daily use of marijuana, is bringing on early death.
  • Marijuana in the workplace.
  • Marijuana. This question does not challenge the medical use of marijuana. Next slide, please.
Keywords: 995, all
Summary: The Special Joint Committee on Initiative Petitions held a public hearing on Initiative Petition 25-10, House Bill 5002, titled “An Act to Restore a Sensible Marijuana Policy,” which would repeal Massachusetts’ adult-use cannabis legalization framework. Chairs Brendan Crighton and Kate Hogan outlined the Article 48 initiative process and explained that the committee is gathering testimony for a report to the legislature. The hearing was organized into expert, proponent, opponent, and public testimony, with written testimony accepted through March 27. The first witness, Jessica Trow of MassBudget, testified in opposition to repeal and focused on cannabis-related revenue and social equity. She said legalization has generated nearly $2 billion statewide since adult-use sales began, with revenue flowing through the Marijuana Regulation Fund, the state sales tax, and local taxes and fees. She emphasized that funds support public health, the Cannabis Control Commission’s social equity work, the Cannabis Social Equity Fund, and municipal budgets, and argued that legalization has created pathways for communities harmed by prohibition. The petition’s spokesperson, Wendy Wakeman, argued in favor of repeal, saying legalization has worsened public health, safety, and quality of life, citing higher potency, addiction, youth use, impaired driving, workplace positives, and black-market concerns. Committee members questioned her about the data sources, the will of the voters, the role of paid signature gatherers, and the petition’s funding, including out-of-state and dark-money concerns. Opponents of the initiative then testified that repeal would harm a regulated industry that has created jobs, tax revenue, and social equity opportunities. Caroline Pino of STEM, Kristen Rogers of Levia, Judith Ledbetter of Project De-Stigmatized Healthcare, and Armani White of Firehouse Dispensary/EON described their businesses, community investments, and personal reliance on cannabis, and warned that repeal would push consumers back to the illicit market and undermine equity programs. In public testimony, Lucas Thayer of the Massachusetts Cannabis Reform Coalition and Jeff Rawson, a chemist and consumer protection advocate, also opposed the measure, arguing that regulated cannabis is safer than unregulated products and that repeal would damage investments and public safety. The hearing ended after the public testimony, and the committee voted to close the hearing.
FL

Florida 2025 Regular Session

October 15, 2025 - 11:30 AM

Transcript Highlights:
  • HAVE ACCESS TO SAFE MEDICAL MARIJUANA.
  • USE AND OUR MEDICAL MARIJUANA PROGRAM WITHIN THE STATE.
  • INSTEAD OUR COSTS ARE THROUGH LICENSE FEES FOR MEDICAL MARIJUANA TREATMENT CENTERS AND CERTIFIED MARIJUANA
  • WE ALSO CERTIFIED EIGHT MARIJUANA TESTING LABORATORIES.
  • THE MARIJUANA TESTING LABORATORIES.
FL

Florida 2026 4th Special Session

February 5, 2026 - 09:00 AM

Transcript Highlights:
  • The bill defines marijuana to include seeds, resin, and edibles that are dispensed from medical marijuana
  • Just because you have a prescription for marijuana, does not entitle you to smoke marijuana and get behind
  • , inhale, smoke marijuana.
  • and 427 testing positive for marijuana.
  • And you know, for me, patients that are being prescribed medical marijuana could lose their medical marijuana